Lisinopril Anhydrous

Lisinopril Anhydrous

SCHEMBL7268245

NCCCC[C@H](NC(CCc1ccccc1)C(=O)O)C(=O)N1CCCC1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Lisinopril Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACE known ✓ P12821 9/20 1.00
LMNA P02545 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lisinopril Anhydrous SCHEMBL15680 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL6679583 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL18712916 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL156900 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL649165 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL24062681 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL13575800 1.00 ACE (1.00) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL7276347 1.00 ACE (1.00) ACELMNASMN1; SMN2
SCHEMBL12433258 0.99 ACE (0.98) ACELMNASMN1; SMN2
Lisinopril Anhydrous SCHEMBL677321 0.99 ACE (0.98) ACELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0336368-B1 N2-(1-carboxy-3-phenylpropyl)-L-lysine derivative and process of producing lysinopril using the compound KANEGAFUCHI CHEMICAL IND (JP) 1995-02-01 EP claimed